Pro Share Advisors LLC Travere Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $48.7 Billion
  • Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Travere Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 21,394 shares of TVTX stock, worth $560,522. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,394
Previous 22,230 3.76%
Holding current value
$560,522
Previous $398,000 20.6%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025
SELL
$13.49 - $21.54 $11,277 - $18,007
-836 Reduced 3.76%
21,394 $316,000
Q1 2025

May 08, 2025
SELL
$17.07 - $23.75 $53,207 - $74,028
-3,117 Reduced 12.3%
22,230 $398,000
Q4 2024

Feb 13, 2025
BUY
$13.65 - $19.85 $94,130 - $136,885
6,896 Added 37.37%
25,347 $441,000
Q3 2024

Nov 13, 2024
BUY
$7.89 - $15.21 $31,512 - $60,748
3,994 Added 27.63%
18,451 $258,000
Q2 2024

Aug 13, 2024
SELL
$5.26 - $8.28 $20,850 - $32,821
-3,964 Reduced 21.52%
14,457 $118,000
Q1 2024

May 08, 2024
BUY
$7.18 - $9.82 $11,179 - $15,289
1,557 Added 9.23%
18,421 $142,000
Q4 2023

Feb 14, 2024
BUY
$5.44 - $9.5 $13,583 - $23,721
2,497 Added 17.38%
16,864 $151,000
Q3 2023

Nov 13, 2023
BUY
$7.64 - $17.25 $504 - $1,138
66 Added 0.46%
14,367 $128,000
Q2 2023

Aug 10, 2023
BUY
$15.3 - $22.61 $39,321 - $58,107
2,570 Added 21.91%
14,301 $219,000
Q1 2023

May 11, 2023
SELL
$17.82 - $22.89 $26,640 - $34,220
-1,495 Reduced 11.3%
11,731 $263,000
Q4 2022

Feb 02, 2023
BUY
$18.47 - $26.14 $20,908 - $29,590
1,132 Added 9.36%
13,226 $278,000
Q3 2022

Nov 04, 2022
BUY
$22.91 - $28.63 $7,010 - $8,760
306 Added 2.6%
12,094 $298,000
Q2 2022

Aug 01, 2022
SELL
$20.94 - $30.01 $122,373 - $175,378
-5,844 Reduced 33.14%
11,788 $285,000
Q1 2022

May 10, 2022
SELL
$23.61 - $30.6 $91,866 - $119,064
-3,891 Reduced 18.08%
17,632 $454,000
Q4 2021

Feb 08, 2022
BUY
$24.34 - $31.17 $26,408 - $33,819
1,085 Added 5.31%
21,523 $669,000
Q3 2021

Nov 12, 2021
SELL
$12.98 - $25.03 $72,026 - $138,891
-5,549 Reduced 21.35%
20,438 $496,000
Q2 2021

Aug 13, 2021
BUY
$14.11 - $26.4 $45,589 - $85,298
3,231 Added 14.2%
25,987 $379,000
Q1 2021

May 14, 2021
BUY
$23.37 - $31.77 $94,368 - $128,287
4,038 Added 21.57%
22,756 $568,000
Q4 2020

Feb 09, 2021
BUY
$19.17 - $27.87 $358,824 - $521,670
18,718 New
18,718 $510,000

Others Institutions Holding TVTX

# of Institutions
230
Shares Held
101M
Call Options Held
1.71M
Put Options Held
401K
View Full List

About Travere Therapeutics, Inc.

TVTX Quotes by TradingView
  • Ticker TVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,173,600
  • Market Cap $1.68B
  • Description
  • Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...
More about TVTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email